News GW Pharma's marijuana-based epilepsy drug approved in US The FDA has approved UK-based GW Pharmaceuticals' drug for a rare form of childhood epilepsy - the first marijuana-based medicine approved in the US.
News FDA advisers back GW's Epidiolex for rare epilepsy UK firm's potential blockbuster on course for approval
News GW files cannabis-based epilepsy drug in EU and US After Sativex disappointment, Epidiolex could transform GW's fortunes.
News NeuroPace brain implant reduces epilepsy seizures in long-te... Data also suggests treatment could improve memory
News UCB recruits Belgian wearables firm for epilepsy study Byteflies' Sensor Dot will help monitor brain, heart and respiration activity.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.